BU-NOT-SET

CONTACT US
How CDMO partnerships can accelerate vaccine development
vaccine development
Insight
Optimising extractables and leachables testing
  • Analytical chemistry
  • Drug product
Optimising Extractables and Leachables Testing
Insight
Ready-to-use (RTU) pre-filled syringes and cartridges system
  • Drug product
  • Manufacturing
vials
Fact sheet
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
  • Drug product
  • Manufacturing
blow fill-seal
Insight
Which biologics trends in the OSD space are set to impact drug development in 2023?
  • Drug product
  • Industry trends
Biologics trends in OSD
Insight
What are the key learnings from 2022 in pharma?
  • Drug product
  • Industry trends
Learnings 2022
Insight
Overcoming the pitfalls of pre-filled syringe filling
  • Drug product
  • Manufacturing
Pre-filled syringe pitfalls
Insight
2023: fill and finish demand expected to continue as the industry faces new challenges
  • Drug product
  • Industry trends
CDMO insight
Insight
What does 2023 hold for oral solid dosage forms?
  • Drug product
  • Industry trends
2023 oral solid dose
Insight
Case study
  • Drug product
Optimising formulation to improve solubility ready for Phase III
Insight
  • Drug product
  • Industry trends
Trends emerging in capsule dosage form development
Fact sheet
  • Corporate
Licensing portfolio
Insight
  • Industry trends
Key trends in pharmaceutical outsourcing
Insight
  • Drug product
  • Industry trends
The latest trends and innovations in oral drug delivery
Insight
  • Corporate
Recipharm invests in African vaccine production
Insight
  • Drug product
  • Industry trends
The future of oral solid dose development and manufacturing
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine